Author:
Cheeseman Sue,Thompson Matthew,Sopwith Will,Godden Paul,Seshagiri Divyagiri,Adedokun Lola,Zucker Kieran,Jain Sunjay,Kotwal Sanjeev,Prescott Stephen,Henry Ann,Joseph Joji,Chilka Sameer,Roulson Jo-An,Weston Michael,Burbidge Simon,Brown Simon,Jagdev Satinder,Ralph Christy,Hall Geoff,Vasudev Naveen S.
Reference30 articles.
1. International rules for multiple primary cancers (ICD-0 third edition);Eur J Cancer Prev,2005
2. Cancer Registration Statistics, England
3. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015;Brown;Br J Cancer,2018
4. Bladder Cancer Statistics2015
5. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol.,2000
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献